Back to companies

Dicerna Pharmaceuticals Inc: Overview

Select Item

Dicerna Pharmaceuticals Inc, a subsidiary of Novo Nordisk AS, is a biopharmaceutical company that discovers and develops therapeutics for the treatment of rare inherited diseases and cancers. It also offers RNAi-based therapies for the treatment liver diseases including rare, viral infections, chronic liver, and cardiovascular diseases. It is headquartered in Lexington, Massachusetts, the US.

 Gain a 360-degree view of Dicerna Pharmaceuticals Inc and make more informed decisions for your business Gain a 360-degree view of Dicerna Pharmaceuticals Inc and make more informed decisions for your business Contact Us
Headquarters United States of America
Address 75 Hayden Avenue, Lexington, Massachusetts, 02421
Industry Pharmaceuticals and Healthcare
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Contact Us

Dicerna Pharmaceuticals Inc premium industry data and analytics

50+

Pipeline Drugs

Identify which of Dicerna Pharmaceuticals Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

20+

Catalyst Calendar

Proactively evaluate Dicerna Pharmaceuticals Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

11+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

10+

Clinical Trials

Determine Dicerna Pharmaceuticals Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

2

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

Image for loader

Competitor Comparison

Key Parameters Dicerna Pharmaceuticals Inc Arrowhead Pharmaceuticals Inc Cumberland Pharmaceuticals Inc Humanigen Inc Viridian Therapeutics Inc
Headquarters United States of America United States of America United States of America United States of America United States of America
City Lexington Pasadena Nashville Short Hills Waltham
State/Province Massachusetts California Tennessee New Jersey Massachusetts
No. of Employees - 525 91 6 96
Entity Type Private Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Contact Us
Executives
Name Position Board Since Age
J. Kevin Buchi Chairman Executive Board 2019 65
Douglas M. Fambrough, III Chief Executive Officer; Director; President Executive Board 2020 52
Douglas Pagan Chief Financial Officer Senior Management 2020 49
Jim Weissman Executive Vice President; Chief Operating Officer Senior Management 2019 59
Rob Ciappenelli Chief Strategy Officer Senior Management 2021 -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Dicerna Pharmaceuticals Inc key executives to enhance your sales strategy Gain insight into Dicerna Pharmaceuticals Inc key executives to enhance your sales strategy Contact Us
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Why are you leaving?